[
    [
        {
            "time": "2021-11-05",
            "original_text": "How IBD Stock Of The Day Eli Lilly Is Taking On Biogen In Alzheimer's",
            "features": {
                "keywords": [
                    "Eli Lilly",
                    "Biogen",
                    "Alzheimer's"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "How IBD Stock Of The Day Eli Lilly Is Taking On Biogen In Alzheimer's",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-11-05",
            "original_text": "Biogen (BIIB) Up on New Data From Phase III Studies on Aduhelm",
            "features": {
                "keywords": [
                    "Biogen",
                    "Aduhelm",
                    "Phase III",
                    "data"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Biogen (BIIB) Up on New Data From Phase III Studies on Aduhelm",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-11-05",
            "original_text": "UPDATE 1-GSK-Vir COVID-19 antibody works as shot in the arm as well as infusion",
            "features": {
                "keywords": [
                    "GSK",
                    "Vir",
                    "COVID-19",
                    "antibody",
                    "shot",
                    "infusion"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals",
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "UPDATE 1-GSK-Vir COVID-19 antibody works as shot in the arm as well as infusion",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-11-05",
            "original_text": "3 Pharma Stocks That Could Make You Richer in November (and Beyond)",
            "features": {
                "keywords": [
                    "Pharma Stocks",
                    "Richer",
                    "November"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "3 Pharma Stocks That Could Make You Richer in November (and Beyond)",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 5,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        }
    ]
]